EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of cf-HPV DNA as an Innovative Biomarker for Predicting the Recurrence or Persistence of Cervical Cancer

Márcia Poinho, Laura L M S Dias, Layane S Pinheiro, Flávia Níniver O Gomes iD, Heidy H M F Rondon, Mikele P de Oliveira iD, Jhonnatan S Souza, Higino F Figueiredo iD, Daniel L Lira, José E Levi, Valquíria C A Martins iD, Kátia L Torres iD

Viruses · 2025

DOI: 10.3390/v17030409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Márcia Poinho und 11 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-Graduação em Imunologia Básica e Aplicada-PPGIBA, Universidade Federal do Amazonas, Manaus 69080-900, AM, Brazil. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, DNA, Viral, Papillomavirus Infections, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação de Amparo à Pesquisa do Estado do Amazonas, Fundação de Amparo à Pesquisa do Estado do Amazonas—FAPEAM.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cervical cancer is highly prevalent among women in Amazonas, Brazil, mainly due to low screening coverage, and is diagnosed at a late stage, which compromises the treatment efficacy and survival rates. After treatment, recurrence is frequent, and there are few follow-up options to detect it. This highlights the urgent need for less-invasive biomarkers to monitor affected patients.

Methods

This study employed real-time PCR, targeting the E7 gene of HPV types 16 and 18 to analyze cell-free DNA from plasma samples from 39 cervical cancer patients treated at the Oncology Control Center Foundation in Amazonas, Brazil. Results: cf-HPV 16 DNA was detected in 54% of the samples before treatment. The socioeconomic and behavioral data showed that 46.2% of the patients had low educational levels, 77% reported having a low income, 79.5% experienced an early sexual activity onset, and 15.4% had never undergone cytological screening. Persistence or recurrence occurred in 30.8% of cases over 4–33 months of follow-up, with cf-HPV DNA detectable in 75% of these cases. Conclusions: cf-HPV DNA in plasma is a promising biomarker for post-treatment surveillance, facilitating the earlier detection of persistence/recurrence. Incorporating this biomarker into clinical protocols could enhance outcomes and survival, particularly in underserved regions like the Amazon, where the access to healthcare is limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsDNA, ViralPapillomavirus InfectionsNeoplasm Recurrence, LocalHuman papillomavirus 16Biomarkers, TumorHumansFemaleMiddle AgedAdultBrazilAgedHuman papillomavirus 18Early Detection of Cancer

Stichwörter der Autor:innen

Amazonian populationHPVcell-free DNAcervical cancerpersistencepost-treatment surveillancerecurrence

Substanzen

DNA, ViralBiomarkers, Tumor

Autor:innen und Institutionen

  • Programa de Pós-Graduação em Imunologia Básica e Aplicada-PPGIBA, Universidade Federal do Amazonas, Manaus 69080-900, AM, Brazil.
  • Faculdade de Ciências Farmacêuticas-FCF, Universidade Federal do Amazonas, Manaus 69080-900, AM, Brazil.
  • Fundação Centro de Controle de Oncologia do Estado do Amazonas, Manaus 69040-010, AM, Brazil.
  • Instituto de Medicina Tropical de São Paulo, Faculdade de Medicina da USP, São Paulo 05403-000, SP, Brazil.
  • Rede de Vigilância Genômica em Saúde, Otimização da Assistência e Pesquisa no Estado do Amazonas-REGESAM, Manaus 69040-010, AM, Brazil.

ORCID-Profile: Flávia Níniver O Gomes, Mikele P de Oliveira, Higino F Figueiredo, Valquíria C A Martins, Kátia L Torres

Förderung

  • National Council for Scientific and Technological Development
  • Fundação de Amparo à Pesquisa do Estado do Amazonas
  • Fundação de Amparo à Pesquisa do Estado do Amazonas—FAPEAM
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Poinho, M., Dias, L. L. M. S., Pinheiro, L. S., Gomes, F. N. O., Rondon, H. H. M. F., de Oliveira, M. P., Souza, J. S., Figueiredo, H. F., Lira, D. L., Levi, J. E., Martins, V. C. A., & Torres, K. L. (2025). The Role of cf-HPV DNA as an Innovative Biomarker for Predicting the Recurrence or Persistence of Cervical Cancer. Viruses. https://doi.org/10.3390/v17030409

Vancouver

Poinho M, Dias LLMS, Pinheiro LS, Gomes FNO, Rondon HHMF, de Oliveira MP, et al. The Role of cf-HPV DNA as an Innovative Biomarker for Predicting the Recurrence or Persistence of Cervical Cancer. Viruses. 2025. doi:10.3390/v17030409

BibTeX
@article{Poinho2025,
  author = {Poinho, Márcia and Dias, Laura L M S and Pinheiro, Layane S and Gomes, Flávia Níniver O and Rondon, Heidy H M F and de Oliveira, Mikele P and Souza, Jhonnatan S and Figueiredo, Higino F and Lira, Daniel L and Levi, José E and Martins, Valquíria C A and Torres, Kátia L},
  title = {The Role of cf-HPV DNA as an Innovative Biomarker for Predicting the Recurrence or Persistence of Cervical Cancer},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17030409}
}
Kostenlos starten →